The World Health Organization (WHO) has launched target product profiles to drive the rapid development of novel tuberculosis (TB) preventive treatment today. The target product profiles characterise the most important product attributes to be considered for developing the best suited TB prevention treatments in future.
One quarter of the global population is estimated to be infected with TB and are at greater risk of developing TB disease, especially those with weakened immunity. Treatment of T
Roles: Everyone: All Users
Regions: Canada , France , Italy , United Kingdom
Topics: Global Health
A special #EndTB Webinar organized by the World Health Organization (WHO) to provide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar is to facilitate better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis and treatment, and better outcomes for the millions affected by TB and drug-resistant TB.
Regions: United Kingdom
Topics: Global Health, Science, Technology, and Innovation